MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
OLMA — Olema Pharmaceuticals, Inc. Common Stock
NasdaqOlema Pharmaceuticals, Inc. Common Stock
$7.94
+0.02(+0.25%)
- O
- 7.90
- H
- 8.23
- L
- 7.79
- V
- 818.54K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About OLMA
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 19, 2020
Employees150
Stock ExchangeNasdaq
Ticker SymbolOLMA
Websitehttps://www.olema.com
Key Financial Statistics
| Market Cap | $719.67M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $6.65 - $36.26 |
| 52-Week Avg Volume | 1.97M |
| VWAP | $8.06 |
| Transactions | 10,218 |
| Total Recorded Bars | 1,476 days |